Results 41 to 50 of about 8,225 (217)

Successful propranolol therapy for infantile hepatic hemangioma with cardiac failure

open access: yesJPGN Reports, EarlyView.
Abstract Infantile hepatic hemangioma (IHH) can cause severe complications such as high‐output cardiac failure and growth faltering, requiring prompt diagnosis and intervention. In the absence of standardized treatment guidelines, propranolol has emerged as an effective and well‐tolerated therapy.
Fadhel Al Ateeqi   +4 more
wiley   +1 more source

Tratamiento médico de los hemangiomas [PDF]

open access: yes, 2004
There are two clearly differentiated attitudes in the treatment of haemangiomas: the expectant attitude and the therapeutic, medical or surgical attitude.
Lloret, P. (Pedro)
core   +1 more source

Clinical characteristics of infantile haemangioma in twins: a retrospective study

open access: yesBMC Pediatrics
Background Infantile hemangioma is one of the most common benign soft tissue tumors in infants. The pathogenesis of infantile hemangioma remains unclear and twin studies regarding its incidence may help clarify disease pathogenesis.
Zhengwei Sun   +3 more
doaj   +1 more source

Evaluating Neurodevelopmental Sequelae of Propranolol Use in Infantile Hemangioma: A Large‐Scale Population‐Based Study

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Propranolol is widely adopted as the first‐line treatment for problematic infantile hemangioma (IH). Despite its efficacy and widespread use, concerns persist about potential long‐term neurodevelopmental risks, given propranolol′s ability to cross the blood‐brain barrier during early development. Objectives To evaluate the long‐term
Khalaf Kridin   +3 more
wiley   +1 more source

Methods of Prediction of Infantile Hemangioma Evolution [PDF]

open access: yes, 2016
Cutaneous hemangioma is the most frequent benign tumor for children. This blood anomaly has a frequency of 10% for children and is more common for females than males.
Ciuc, Mihai A
core  

Ocular manifestations of Sturge–Weber syndrome: pathogenesis, diagnosis, and management [PDF]

open access: yes, 2016
Sturge-Weber syndrome has been included in the group of phakomatoses that is characterized by hamartomas involving the brain, skin, and eyes. The characteristic facial port-wine stain, involving the first branch of the trigeminal nerve and the embryonic ...
Abdolrahimzadeh, Solmaz   +4 more
core   +1 more source

NOGOB receptor–mediated RAS signaling pathway is a target for suppressing proliferating hemangioma

open access: yesJCI Insight, 2021
Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well
Wenquan Hu   +9 more
doaj   +1 more source

Yield of Whole Genome Sequencing for Pathogenic Single Nucleotide Variants in Congenital Heart Disease: A Systematic Review and Meta‐Analysis

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective This systematic review and meta‐analysis aimed to assess the diagnostic yield of pathogenic or likely pathogenic (P/LP) single nucleotide variants (SNVs) using whole genome sequencing (WGS) in congenital heart disease (CHD). Methods A systematic search of three databases (2000–2024) was conducted, and two reviewers independently ...
Hiba J. Mustafa   +7 more
wiley   +1 more source

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients [PDF]

open access: yes, 2015
[Background] Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumors: hemangioblastomas in the central nervous system (CNS) and retina ...
Albiñana, Virginia   +7 more
core   +1 more source

Kaposiform hemangioendothelioma: Diagnosis and treatment

open access: yesPediatric Investigation, EarlyView.
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Yi Tian   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy